Ten biomedical researchers filed suit Thursday against a renowned academic journal company after it was involved in what the researchers called a politically motivated retraction earlier this year of three scientific papers on the incidence of complications from the abortion pill mifepristone. 

Two of the retracted papers, written by physicians and academics affiliated with the anti-abortion Charlotte Lozier Institute and the American Association of Pro-Life Obstetricians and Gynecologists, were cited in April 2023 by U.S. District Court Judge Matthew Kacsmaryk in his order to suspend the Food and Drug Administration’s approval of mifepristone.